参考文献/References:
[1] Said SI,M utt V.Polupeptide with broad biological activity:Isolation from the small intestinal[J].Science,1970,69:1217-1218.
[2] HarmarAJ,Arimura A.International union of pharmacology Ⅹ Ⅷ.nomenclature of receptor for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide[J].Pharmacol Rev,1998,50(2):265-270.
[3] Fahrnkrug J.Glycine-extended processing intermediate of proVIP:A new bioactive form of VIP in the rat[J].Biomed Res,1992,13:19-23.
[4] Bolin DR,Cottrell J.Strycture-activity studies on the vasoactive intestinal peptide pharmacophore[J].Int J Pritein Res,1995,46:279-289.
[5] Wulff B,Moller-Knusen S.The C-terminal part of VIP is importan for receptor binding and activation,as evidenced by chimeric constructs of VIP/secretin[J].FEBS Lett,1997,413(3):405-408.
[6] Usdin TB,Bonner TI.Two receptors for vasoactive intestinal polypeptide with similar specificity and complementary distributions[J].Endocrinology,1994,35(6):2662-2680.
[7] Gaudin P,Couvineau A.Role of cysteine residues in the N-terminal extracellular domain of the humun VIP1 receptor for ligand:A site-directed mutagenesis study[J].Ann NY Acad Sci,1996,805:585-589.
[8] Nicol P,Du K.Site-directed mutagenesis of human VIP1 versus VIP2 receptors[J].Ann N Y Acad Sci,1998,865:378-381.
[9] Nicol P,Du K.Site-directed mutagenesis of humann vasoactive intestinal peptide receptor subtypes VIP1 and VIP2:evidence for difference in the structure-function relationship[J].J Phannacol Exp Ther,1998,284(2):744-750.
[10] Sreedharan SP,Patel DR.Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor[J].Biochem Biophys Res Commun,1993,193(2):546-553.
[11] Lutz EM,Shen S.Structure of the human VIPR2 sene for vasoactive intestinal peptide receptor type?[J].FEBS Lett,1999,458:197-203.
[12] Gaudin P,Maoret JJ.Constitutive activation of the human vasoactive intestinal peptide 1 receptor,a member of the new class Ⅱ family of G protein-coupled receptors[J].J Biol Chem,1998,273 (9):4990-4996.
[13] Reubi JC.In vitro identification of vasoactive intestinal peptide receptors in human tumors:implications for tumor imaging[J].J Nucl Med,1995,36(10):1846-1895.
[14] Reubi JC,Lamberts ST.Receptor imaging of human diseases using radiolabeled peptides[J].J Recept Signal Transduct Res,1995,15(1-4):379-392.
[15] ReubiJC,Waser B.Receptor autoradiogrphic evaluation of cholecystokinin,neurotensin,somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples:Where are they really located?[J].Int J Cancer,1999,81(3):376-386.
[16] Virgolini I.Vasoactive intestinal peptide receptor scintigraphy[J].J Nucl Med,1995,36(10):1732-1739.
[17] Virgolini I,Raderer M.Vasoactive intestinal peptide receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumor[J].N Engl J Med,1994,331(17):1116-1121.
[18] Virgolini I,Raderer M.Iodine-123-vasoactive intestinal peptide receptor scanning up-to-date of imaging results in patients with adeocarcinomas and endocrine tumor of the gastrointestinal tract[J].Nucl Med Biol,1996,23(6):685-692.
[19] Pallela VR,Thakur ML.99Tcm-labeled vasoactive intestinal peptide receptor agonist:functional studies[J].J Nucl Med,1999,40(2):352-360.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]